COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study LYW Lee, JB Cazier, T Starkey, CD Turnbull, UKCCMP Team, R Kerr, ... The Lancet, 2020 | 1260 | 2020 |
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study LYW Lee, JB Cazier, T Starkey, SEW Briggs, R Arnold, V Bisht, S Booth, ... The Lancet Oncology 21 (10), 1309-1316, 2020 | 660 | 2020 |
HER2 expression in gastric cancer: rare, heterogeneous and of no prognostic value–conclusions from 924 cases of two independent series H Grabsch, S Sivakumar, S Gray, HE Gabbert, W Müller Analytical Cellular Pathology 32 (1-2), 57-65, 2010 | 405 | 2010 |
Evaluation of pre-analytical factors affecting plasma DNA analysis H Markus, T Contente-Cuomo, M Farooq, WS Liang, MJ Borad, ... Scientific reports 8 (1), 1-10, 2018 | 138 | 2018 |
Biomarkers of response to PD-1 pathway blockade H Li, PA van der Merwe, S Sivakumar British Journal of Cancer, 1-13, 2022 | 110 | 2022 |
Nerve fibers in the tumor microenvironment in neurotropic cancer-pancreatic cancer and cholangiocarcinoma. X Tan, S Sivakumar, J Bednarsch, G Wiltberger, JN Kather, J Niehues, ... Oncogene, 2020 | 78 | 2020 |
The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19 I Anil, R Arnold, S Benkwitz-Beford, S Branford, N Campton, JB Cazier, ... The Lancet Oncology 21 (5), 622-624, 2020 | 71 | 2020 |
Cell-free DNA TAPS provides multimodal information for early cancer detection P Siejka-Zielińska, J Cheng, F Jackson, Y Liu, Z Soonawalla, S Reddy, ... Science Advances 7 (36), eabh0534, 2021 | 60 | 2021 |
Master regulators of oncogenic KRAS response in pancreatic cancer: an integrative network biology analysis S Sivakumar, I de Santiago, L Chlon, F Markowetz PLoS medicine 14 (1), 2017 | 50 | 2017 |
Immunophenotypes of pancreatic ductal adenocarcinoma: Meta‐analysis of transcriptional subtypes I De Santiago, C Yau, L Heij, MR Middleton, F Markowetz, HI Grabsch, ... International journal of cancer 145 (4), 1125-1137, 2019 | 49 | 2019 |
Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer S Sivakumar, E Abu-Shah, DJ Ahern, EH Arbe-Barnes, AK Jainarayanan, ... Cancers 13 (8), 1776, 2021 | 39 | 2021 |
Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer JJ Jaworski, RD Morgan, S Sivakumar Cancers 12 (12), 3704, 2020 | 25 | 2020 |
Collective intelligence for translational medicine: Crowdsourcing insights and innovation from an interdisciplinary biomedical research community E Jane Budge, S Maria Tsoti, D James Howgate, S Sivakumar, M Jalali Annals of medicine 47 (7), 570-575, 2015 | 23 | 2015 |
A New Combination Immunotherapy in Advanced Melanoma AE Frampton, S Sivakumar New England Journal of Medicine 386 (1), 91-92, 2022 | 19 | 2022 |
Nerve Fibers in the Tumor Microenvironment Are Co-Localized with Lymphoid Aggregates in Pancreatic Cancer LR Heij, X Tan, JN Kather, JM Niehues, S Sivakumar, N Heussen, ... Journal of Clinical Medicine 10 (3), 490, 2021 | 18 | 2021 |
Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case–control study P San Tan, C Garriga, A Clift, W Liao, M Patone, C Coupland, ... Gut, 2022 | 17 | 2022 |
Nerve Fibers in the Tumor Microenvironment as a Novel Biomarker for Oncological Outcome in Patients Undergoing Surgery for Perihilar Cholangiocarcinoma J Bednarsch, J Kather, X Tan, S Sivakumar, C Cacchi, G Wiltberger, ... Liver Cancer 10 (3), 260-274, 2021 | 17 | 2021 |
Tumor heterogeneity: does it matter? C Turnquist, RA Watson, A Protheroe, C Verrill, S Sivakumar Expert review of anticancer therapy 19 (10), 857-867, 2019 | 16 | 2019 |
Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma T Chouari, FS La Costa, N Merali, MD Jessel, S Sivakumar, N Annels, ... Cancers 15 (17), 4265, 2023 | 12 | 2023 |
The Presence of Small Nerve Fibers in the Tumor Microenvironment as Predictive Biomarker of Oncological Outcome Following Partial Hepatectomy for Intrahepatic Cholangiocarcinoma J Bednarsch, X Tan, Z Czigany, D Liu, SA Lang, S Sivakumar, JN Kather, ... Cancers 13 (15), 3661, 2021 | 12 | 2021 |